Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yating Hao, Huiyuan Li, Yang Li, Mingen Lyu, Donglei Zhang, Rongfeng Fu, Yue Guan, Shixuan Wang, Boyang Sun, Xueqing Dou & Renchi Yang. (2017) Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia. Autoimmunity 50:5, pages 283-292.
Read now
Read now
A Antonelli, C Ferri, SM Ferrari, C Mancusi, M Colaci, M Sebastiani & P Fallahi. (2011) IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. Scandinavian Journal of Rheumatology 40:6, pages 453-456.
Read now
Read now
Michael R York. (2011) Novel insights on the role of the innate immune system in systemic sclerosis. Expert Review of Clinical Immunology 7:4, pages 481-489.
Read now
Read now
G Papp, IF Horvath, S Barath, E Gyimesi, S Sipka, P Szodoray & M Zeher. (2011) Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis. Scandinavian Journal of Rheumatology 40:3, pages 205-210.
Read now
Read now
Articles from other publishers (29)
Li Zhang, Dong Zheng, Yuemei Yan, Yong Yu, Ruizhen Chen, Zheng Li, Peter A. Greer, Tianqing Peng & Qiang Wang. (2022) Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis Research & Therapy 24:1.
Crossref
Crossref
John Henderson & Steven O’Reilly. (2021) The emerging role of metabolism in fibrosis. Trends in Endocrinology & Metabolism 32:8, pages 639-653.
Crossref
Crossref
Benjamin Thoreau, Benjamin Chaigne, Arthur Renaud & Luc Mouthon. (2021) Pathophysiology of systemic sclerosis. La Presse Médicale 50:1, pages 104087.
Crossref
Crossref
Alireza Hejrati, Alireza Rafiei, Mohsen Soltanshahi, Shahnaz Hosseinzadeh, Mina Dabiri, Mahdi Taghadosi, Saeid Taghiloo, Davood Bashash, Fatemeh Khorshidi & Parisa Zafari. (2020) Innate immune response in systemic autoimmune diseases: a potential target of therapy. Inflammopharmacology 28:6, pages 1421-1438.
Crossref
Crossref
Kazumichi Abe & Hiromasa Ohira. 2019. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases
23
33
.
Juliette Peltzer, Marc Aletti, Nadira Frescaline, Elodie Busson, Jean-Jacques Lataillade & Christophe Martinaud. (2018) Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges. Frontiers in Immunology 9.
Crossref
Crossref
Andréa Tavares Dantas, Anderson Rodrigues de Almeida, Maria Clara Pinheiro Duarte Sampaio, Marina Ferraz Cordeiro, Priscilla Stela Santana de Oliveira, Henrique de Ataíde Mariz, Michelly Cristiny Pereira, Moacyr Jesus Barreto de Melo Rego, Ivan da Rocha Pitta, Angela Luzia Branco Pinto Duarte & Maíra Galdino da Rocha Pitta. (2018) Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations. Immunology Letters 198, pages 12-16.
Crossref
Crossref
Alsya J. Affandi, Tiago Carvalheiro, Timothy R.D.J. Radstake & Wioleta Marut. (2018) Dendritic cells in systemic sclerosis: Advances from human and mice studies. Immunology Letters 195, pages 18-29.
Crossref
Crossref
Steven O’Reilly. (2018) Toll Like Receptors in systemic sclerosis: An emerging target. Immunology Letters 195, pages 2-8.
Crossref
Crossref
Francesco Boin & Carlo Chizzolini. 2017. Scleroderma. Scleroderma
161
195
.
Rosa M. Montero, Gurjeet Bhangal, Charles D. Pusey, Andrew H. Frankel & Frederick W. K. Tam. (2016) CCL18 synergises with high concentrations of glucose in stimulating fibronectin production in human renal tubuloepithelial cells. BMC Nephrology 17:1.
Crossref
Crossref
Ji-Qing Chen, Peter Szodoray & Margit Zeher. (2015) Toll-Like Receptor Pathways in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 50:1, pages 1-17.
Crossref
Crossref
Yu Liu, Heng Yin, Ming Zhao & Qianjin Lu. (2013) TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 47:2, pages 136-147.
Crossref
Crossref
Yuen Yee Ho, David Lagares, Andrew M. Tager & Mohit Kapoor. (2014) Fibrosis—a lethal component of systemic sclerosis. Nature Reviews Rheumatology 10:7, pages 390-402.
Crossref
Crossref
Hiromasa Ohira & Hiroshi Watanabe. (2014) Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis. Hepatology Research 44:4, pages 377-383.
Crossref
Crossref
Steven O’Reilly. (2013) Innate immunity in systemic sclerosis pathogenesis. Clinical Science 126:5, pages 329-337.
Crossref
Crossref
P Cipriani, P Di Benedetto, V Liakouli, B Del Papa, M Di Padova, M Di Ianni, A Marrelli, E Alesse & R Giacomelli. (2013) Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. Clinical and Experimental Immunology 173:2, pages 195-206.
Crossref
Crossref
Jing Li, Xiaohui Wang, Fengchun Zhang & Hang Yin. (2013) Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacology & Therapeutics 138:3, pages 441-451.
Crossref
Crossref
T. Miyagaki, M. Sugaya, H. Suga, H. Ohmatsu, H. Fujita, Y. Asano, Y. Tada, T. Kadono & S. Sato. (2013) Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis. Journal of the European Academy of Dermatology and Venereology 27:1, pages e60-e67.
Crossref
Crossref
Marzena Ciechomska, Rachel Cant, James Finnigan, Jacob M. van Laar & Steven O'Reilly. (2013) Role of toll-like receptors in systemic sclerosis. Expert Reviews in Molecular Medicine 15.
Crossref
Crossref
Theresa T. Lu. (2011) Dendritic Cells: Novel Players in Fibrosis and Scleroderma. Current Rheumatology Reports 14:1, pages 30-38.
Crossref
Crossref
Francesco Boin & Carlo Chizzolini. 2012. Scleroderma. Scleroderma
165
189
.
K.C.M. Santegoets, L. van Bon, W.B. van den Berg, M.H. Wenink & T.R.D.J. Radstake. (2011) Toll-like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?. FEBS Letters 585:23, pages 3660-3666.
Crossref
Crossref
L. van Bon, M. Cossu & T.R.D.J. Radstake. (2011) An update on an immune system that goes awry in systemic sclerosis. Current Opinion in Rheumatology 23:6, pages 505-510.
Crossref
Crossref
Ronald A. Reilkoff, Richard Bucala & Erica L. Herzog. (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nature Reviews Immunology 11:6, pages 427-435.
Crossref
Crossref
T. W. van Hal, L. van Bon & T. R. D. J. Radstake. (2011) A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis. International Journal of Rheumatology 2011, pages 1-7.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Rheumatology 22:6, pages 704-712.
Crossref
Crossref
Robert J Homer & Erica L Herzog. (2010) Recent advances in pulmonary fibrosis: implications for scleroderma. Current Opinion in Rheumatology 22:6, pages 683-689.
Crossref
Crossref
S P Atamas, I G Luzina, J Ingels, J Choi, W K Wong, D E Furst, P J Clements & A E Postlethwaite. (2010) Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma). Clinical and Experimental Immunology 161:3, pages 426-435.
Crossref
Crossref